Japanese Trade Distributors Stock News

TSE:6323
TSE:6323Semiconductor

3 Japanese Founder Led Tech Stocks Retail Investors Should Watch

Global data is sending mixed signals, with services cooling in the UK and parts of Europe, manufacturing momentum easing in India, and inflation pressures shifting across Canada, Japan and Australia. In choppy conditions like this, many investors look for founders who still run their companies and have meaningful skin in the game. The Top Founder-Led Companies screener focuses on businesses where capital is used carefully and leadership is personally invested in long term outcomes. In this...
TSE:4516
TSE:4516Pharmaceuticals

Deepened Boston Children’s Partnership Could Be A Game Changer For Nippon Shinyaku (TSE:4516)

Nippon Shinyaku Co., Ltd. has entered into a Sponsored Research Agreement with Boston Children's Hospital to co-develop innovative neurology drugs, building on their earlier collaboration and leveraging the NS Pharma Innovation Research Partnering team in Cambridge, MA. This alliance signals Nippon Shinyaku’s intent to deepen its presence in neurology by pairing hospital-based scientific discovery with its own drug development capabilities to address unmet patient needs. We’ll examine how...
TSE:3038
TSE:3038Consumer Retailing

Kobe Bussan (TSE:3038) Following Half Year Earnings, Is The Valuation Story Changing

Why Kobe Bussan’s Latest Earnings Matter For Investors Kobe Bussan (TSE:3038) has attracted fresh attention after reporting half year earnings to April 30, 2026, with sales of ¥286,172 million and net income of ¥16,501 million compared with the previous year’s period. See our latest analysis for Kobe Bussan. The latest half-year earnings have arrived against a weak share price backdrop for Kobe Bussan, with the stock at ¥2,604.5 after a 1-year total shareholder return that declined 42.03% and...
TSE:6763
TSE:6763Electronic

Top Asian Dividend Stocks To Consider In June 2026

As Asian markets navigate a complex landscape of economic shifts and policy changes, investors are increasingly turning their attention to dividend stocks as a potential source of steady income. In light of Japan's significant interest rate hike and China's mixed economic signals, identifying stocks with strong dividend yields can offer a measure of stability in these uncertain times.
TSE:6869
TSE:6869Medical Equipment

What Sysmex (TSE:6869)'s Nu.Q NETs Collaboration With VolitionRx Means For Shareholders

In June 2026, VolitionRx Limited announced it had entered into a collaboration with Sysmex Corporation to optimize VolitionRx’s Nu.Q NETs H3.1 assay on Sysmex’s platform, following successful transfer of the assay and with a focus on diseases linked to NETosis. The agreement opens access to a very large US$3.80 billion total addressable market for the Nu.Q NETs assay, which could broaden Sysmex’s role in specialized diagnostics. Next, we examine how integrating the Nu.Q NETs assay into...
TSE:4519
TSE:4519Pharmaceuticals

Japanese Stocks With Strong Cash Flow the Market May Be Mispricing

With global growth expectations under pressure, inflation still a concern in many regions and bond yields pushing higher, investors are increasingly drawn to companies that can stand on their own financial feet. The High Quality Undervalued Stocks screener focuses on businesses with solid cash flows and balance sheets that the market has not fully appreciated. These stocks will not rely solely on economic tailwinds, which can matter when services and manufacturing are moving at different...
TSE:4088
TSE:4088Chemicals

Air Water (TSE:4088) Is Up 5.4% After Launching Accountability Probe Into Past Accounting Practices

Air Water Inc. recently held board meetings and has now set up an external Accountability Assessment Committee after uncovering inappropriate accounting treatments across its group from fiscal 2020 to mid‑fiscal 2025. This move, alongside plans to amend past securities reports and potentially pursue legal action against responsible directors, marks a significant escalation in the company’s governance and transparency efforts. We’ll now explore how the new Accountability Assessment Committee...
TSE:4417
TSE:4417IT

Asian Market's Top 3 Value Stock Picks For Intrinsic Growth Potential

Amid a backdrop of mixed economic signals and shifting monetary policies in Asia, investors are increasingly focusing on value opportunities within the region's stock markets. Identifying undervalued stocks with intrinsic growth potential can be particularly appealing in such an environment, as these investments may offer resilience and long-term benefits despite broader market uncertainties.
TSE:6594
TSE:6594Electrical

Nidec (TSE:6594) Stock Could Be 14% Undervalued After Governance Overhaul

Why Nidec’s governance overhaul matters for stock investors Nidec (TSE:6594) has put governance firmly in focus, installing Independent Outside Director Soichiro Sakuma as Chair of the Board and shifting key committees to fully external leadership. These changes sit alongside amendments to the Articles of Incorporation that redefine who convenes and chairs shareholder and board meetings, signaling a clearer separation between management roles and oversight functions. See our latest analysis...
TSE:7203
TSE:7203Auto

3 Japanese Stocks With Dividends And Dividend Coverage In Focus

With growth signals mixed across Europe and the UK, and inflation pressures easing only gradually, dependable income has become a bigger part of many investors’ plans. Dividend Powerhouses aim to meet that need by focusing on companies paying more than a 5% yield, where the dividend is well covered, growing and relatively stable. This can appeal if you want regular cash flow without having to chase short term moves in rates or economic data. In this article, you will see three stocks from the...
TSE:9433
TSE:9433Wireless Telecom

Will KDDI's (TSE:9433) Expanded Aeris IoT and AI Automation Push Reshape Its Investment Narrative?

KDDI Corporation previously announced the successful completion of its IoT connectivity management service agreement with Aeris, extending its use of the Aeris IoT Accelerator platform that oversees 0.10 billion IoT devices and 0.04 billion connected vehicles worldwide while benefiting from recent performance, modernization, and global connectivity upgrades. At the same time, KDDI is working with partners in the TM Forum Catalyst Program on an AI-powered multi-agent framework that links...
TSE:8278
TSE:8278Consumer Retailing

Fuji (TSE:8278) Stock Could Be Below Fair Value After Capital Efficiency Update

Fuji (TSE:8278) has updated its capital cost and share price conscious management framework, refining measures first outlined in 2025 to better align management decisions with capital efficiency and long term shareholder interests. See our latest analysis for Fuji. Fuji's latest update on capital cost and share price conscious management comes after a period where the share price has eased, with a 30 day share price return of down 9% and a year to date share price return of down 10.59%. The 3...
TSE:8984
TSE:8984REITs

Daiwa House REIT Investment (TSE:8984) Stock Could Face Fair Value Questions After Dividend Cut

Daiwa House REIT Investment (TSE:8984) recently announced a semi annual dividend of ¥2,483 per share, payable on November 10, 2026, with an ex dividend date of August 28 and a record date of August 31. See our latest analysis for Daiwa House REIT Investment. The dividend reduction lands at a time when Daiwa House REIT Investment’s share price has fallen 17.31% year to date and 8.28% over the past 90 days. Its 1 year total shareholder return, which includes distributions, is 2.62%, pointing to...
TSE:4502
TSE:4502Pharmaceuticals

How Phase 3 Wins In Narcolepsy And Psoriasis At Takeda Pharmaceutical (TSE:4502) Have Changed Its Investment Story

Takeda Pharmaceutical recently reported additional Phase 3 data at SLEEP 2026 showing its investigational orexin agonist oveporexton improved daily functioning, cognition and nighttime sleep in narcolepsy type 1, while the FDA is reviewing its New Drug Application under Priority Review with a PDUFA decision expected in the third quarter of this year. In parallel, Takeda announced that its oral TYK2 inhibitor zasocitinib achieved superior complete skin clearance and other efficacy endpoints...
TSE:285A
TSE:285ASemiconductor

3 Japanese Stocks With Earnings Growth And Balance Sheet Support

Global growth signals are mixed, with services under pressure in parts of Europe, inflation trends uneven and central banks keeping a close eye on rates. In this kind of cross‑current, many investors are looking for stocks where analysts still see strong earnings growth potential and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener focuses on by filtering for companies expected to grow earnings over the next 3 years while...